Market Research Reports, Inc. has announced the addition of “Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 2014” research report to their offering. more information visit - http://mrr.cm/Zoj
2. www.MarketResearchReports.com
Introduction to Report
Launch Date: March 11, 2014
Number of Pages: 386
Geography Coverage: Global
Available Format: PDF
Price For Single User License: USD 1,514
Price For Single Site License: USD 3,028
Price For Global User License: USD 4,543
Delivery Time: Within 24 Hours (During Working Days)
3. www.MarketResearchReports.com
About the Report
The present Competitive Intelligence Report about
Biosimilar and Biosuperior Therapeutic Antibodies 2014
provides a competitor evaluation in the field of
recombinant monoclonal and polyclonal antibodies in the
market, in the pipeline as next generation products and as
biosimilar versions as of March 2014.
Marketed antibodies are attractive for companies to
create next generation variants and biosimilar copies
because they represent clinically and commercially
validated products. New technologies such as Fc
engineering, polyclonal mixtures, antibody drug
conjugates or bispecific molecules as well as the
expiration of patents stimulate the discovery and
development of biosimilar and biosuperior/biobetter
molecules.
4. www.MarketResearchReports.com
Research Findings
Total sales of recombinant therapeutic monoclonal
antibodies originating from companies located in
regulated markets reached US$ 75.7 bln in the year 2013.
Cumulated 2013 sales of branded therapeutic antibodies
approaching patent expiry and, therefore, target of
biosimilar substitution, reached US$ 58.6 bln.
The report lists specifically for each target the branded
products with their 2013 sales and up-side indications in
development, as well as follower, biosuperior and
biosimilar antibody drug candidates in development.
5. www.MarketResearchReports.com
Competitor projects are listed in a tabular format providing
information on:
Drug Codes,
Target / Mechanism of Action,
Class of Compound,
Company,
Product Category,
Indication,
R&D Stage
6. www.MarketResearchReports.com
Report Coverage
1. 2013 Sales of Recombinant Therapeutic Antibodies
2. CD20 Antibodies - Rituximab Biosimilars and
Biobetters/Biosuperiors
3. Her2 Antibodies - Trastuzumab Biosimilars and
Biobetters/Biosuperiors
4. VEGF Antibodies – Bevacizumab and Ranibizumab
Biosimilars and Biosuperiors
5. EGF-R Antibodies –Biosimilars and Biosuperiors
6. TNF Antibodies –Biosimilars and Biosuperiors
7. IgE Antibodies: Xolair, Biosuperiors & Biosimilars
8. Interleukin-6 Receptor (IL-6R) Antibodies: Actemra,
Biosuperiors & Biosimilars
9. GPIIb/IIIa Antibodies: ReoPro, Biosuperios & Biosimilars
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
7. www.MarketResearchReports.com
Report Coverage Continues…
10. CD52 Antibodies: Lemtrada, Biosuperios & Biosimilars
11. Apha4/beta1/7 Antibodies: Tysabri, Biosuperiors &
Biosimilars
12. Complement C5 Antibodies: Soliris, Biosuperiors &
Biosimilars
13. Respiratory Syncytial Virus (RSV): Synagis, Biosuperiors &
Biosimilars
14. RANKL Antibodies: Prolia/XGEVA, Biosuperiors & Biosimilars
15. CD80/86 (B7-1/B7-2) Antibodies: Orencia; Nulojix,
Biosuperiors & Biosimilars
16. Interleukin-12/-23 Antibodies: Stelara, Biosuperiors &
Biosimilars
17. Corporate Biosimilar and Biosuperior Therapeutic Antibody
Pipelines
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
8. www.MarketResearchReports.com
Company Coverage (Partial List)
1. AbbVie
2. Ablynx
3. Actavis (Watson Pharmaceuticals)
4. Actogenix
5. ADC Therapeutics
6. Affitech
7. AIMM Therapeutics
8. Alder Biopharmaceuticals
9. Alexion Pharmaceuticals
10. Allergan
11. Allozyne
12. Alopexx Oncology
13. Alteogen
14. Ambrx
15. Amega Biotech
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
9. www.MarketResearchReports.com
Custom Research:
Are you an industry
professional, entrepreneur, venture capitalist, investors
and organization, then let us know your specific
research requirements. Our goal is to cater to your
requirements be it for a custom market research
project, syndicated research report on a specific market
or industry sector, newsletter creation, case study
development or anything else related to marketing
research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center
10. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/Zoj
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : info@marketresearchreports.com
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)